Neurofibromatosis Type 2
📧 Sign up to get email alerts when something new happens for Neurofibromatosis Type 2.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas [Phase 2]
Phase 2 trial of axitinib in Neurofibromatosis Type 2 with progressive vestibular schwannomas completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors [Phase 2]
A Phase 2 clinical trial evaluating icotinib in patients with Neurofibromatosis Type 2 and related vestibular schwannomas has been completed…
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas [Phase 2]
Phase 2 trial update for AZD2014 in Neurofibromatosis 2 patients with progressive or symptomatic meningiomas has completed; results posted i…
-
CLINICAL_TRIALS trial_result · 2020-05-27Clinical Trial Update: Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas [Phase 2]
Phase 2 trial evaluating bevacizumab in children and young adults with Neurofibromatosis Type 2 and progressive vestibular schwannomas has c…
-
CLINICAL_TRIALS trial_result · 2018-11-26Clinical Trial Update: Concentration and Activity of Lapatinib in Vestibular Schwannomas [EARLY_Phase 1]
Early-phase trial updating concentration and activity of lapatinib in vestibular schwannomas, completed with results posted in 2018.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: WES of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data
This clinical trial compares whole-exome sequencing of NF2-associated vestibular schwannomas with sporadic cases and correlates findings wit…
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2) [Phase 2]
Phase 2 clinical trial evaluating bevacizumab for symptomatic vestibular schwannoma in patients with neurofibromatosis type 2 has completed …
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma [Phase 2]
A Phase 2 trial of Antineoplaston Therapy for neurofibroma and schwannoma sponsored by Burzynski Research Institute has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Efficacy and Safety Study of RAD001 in the Growth of the Vestibular Schwannoma(s) in Neurofibromatosis 2 (NF2) Patients [Phase 2]
Phase 2 trial evaluating RAD001 (everolimus) for growth of vestibular schwannomas in Neurofibromatosis type 2; the study has completed and r…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors [Phase 2]
A Phase 2 clinical trial evaluating Endostatin for vestibular schwannoma in Neurofibromatosis Type 2–related tumors has completed enrollment…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype [NA]
Completed clinical trial evaluating resiliency training delivered via Skype videoconferencing for patients with Neurofibromatosis types 1, 2…
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors [Phase 2]
Phase 2 study of lapatinib in children and adults with Neurofibromatosis Type 2 and NF2-related tumors has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2 [Phase 2]
This document reports the completion of a Phase II trial evaluating a multichannel auditory brain stem implant for deafness in patients who …
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 Tumors [Phase 1]
Phase 1 clinical trial update for an implant to treat hearing loss following Neurofibromatosis type 2 tumor removal; the study is completed.…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Analysis of NF2 Mutations in Radiation-Related Neural Tumors
The completed study analyzes NF2 (neurofibromatosis type 2) mutations in radiation-related neural tumors to better understand their genetic …